Trial no.:
|
PACTR202008763735746 |
Date of Approval:
|
03/08/2020 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Pericapsular Nerve Group (PENG) Block for Hip Fracture; a prospective randomized controlled trial |
Official scientific title |
Pericapsular Nerve Group (PENG) Block for Hip Fracture; a prospective randomized controlled trial |
Brief summary describing the background
and objectives of the trial
|
Hip fracture is a common orthopedic emergency in the elderly, and it is associated with significant morbidity and mortality.1 Surgical reduction and fixation are the definitive treatment in most patients.2 Effective perioperative analgesia that minimizes the need for opioids and related adverse effects (such as delirium) is essential in this patient population.3,4
Regional analgesic techniques, including femoral nerve (FN) block, fascia iliaca block (FIB), and 3-in-1 FN block, are popular analgesic strategies, due mainly to their opioid-sparing effects and reduction in opioid-related adverse effects.5–7 The effect size of analgesia from these blocks is only moderate,8 and literature suggests that the obturator nerve (ON) is not covered.9,10
The anterior hip capsule is innervated by the ON, accessory obturator nerve (AON), and FN as reported by previous anatomic studies.11–13 The anterior capsule is the most richly innervated
section of the joint,14 suggesting these nerves should be the main targets for hip analgesia. A recent anatomical study by Short et al 15 confirmed the innervation of the anterior hip by these 3 main nerves, but also found that the AON and FN play a greater role in the anterior hip innervation than previously reported.16
The aim of this study is to evaluate the analgesic efficacy of PENG block in patients undergoing surgery for hip fractures.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
perioperative analgesia for hip fracture surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
24/06/2019 |
Actual trial start date |
|
Anticipated date of last follow up |
24/12/2019 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|